APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bicalutamide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bicalutamide Tablets Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchBicalutamide Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Bicalutamide Tablets Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Bicalutamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bicalutamide Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bicalutamide Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bicalutamide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bicalutamide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bicalutamide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bicalutamide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bicalutamide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Bicalutamide Tablets include HISUN, Fosun Pharma, FORWARD, AstraZeneca and CordenPharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Bicalutamide Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bicalutamide Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Bicalutamide Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bicalutamide Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bicalutamide Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Bicalutamide Tablets sales, projected growth trends, production technology, application and end-user industry.

Bicalutamide Tablets Segment by Company

HISUN

Fosun Pharma

FORWARD

AstraZeneca

CordenPharma

Bicalutamide Tablets Segment by Type

14 Tablets Per Box

28 Tablets Per Box

Bicalutamide Tablets Segment by Application

Hospital

Clinic

Bicalutamide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bicalutamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bicalutamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bicalutamide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Bicalutamide Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Bicalutamide Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bicalutamide Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bicalutamide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 14 Tablets Per Box Major Manufacturers Table 3. 28 Tablets Per Box Major Manufacturers Table 4. Global Bicalutamide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Bicalutamide Tablets Industry Trends Table 8. Bicalutamide Tablets Industry Drivers Table 9. Bicalutamide Tablets Industry Opportunities and Challenges Table 10. Bicalutamide Tablets Industry Restraints Table 11. Global Bicalutamide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Bicalutamide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Bicalutamide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Bicalutamide Tablets Revenue Market Share by Region (2021-2026) Table 15. Global Bicalutamide Tablets Revenue Market Share by Region (2027-2032) Table 16. Global Bicalutamide Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Bicalutamide Tablets Sales by Region (2021-2026) & (k units) Table 18. Global Bicalutamide Tablets Sales by Region (2027-2032) & (k units) Table 19. Global Bicalutamide Tablets Sales Market Share by Region (2021-2026) Table 20. Global Bicalutamide Tablets Sales Market Share by Region (2027-2032) Table 21. Global Bicalutamide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Bicalutamide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Bicalutamide Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Bicalutamide Tablets Sales Market Share by Manufacturers (2021-2026) Table 25. Global Bicalutamide Tablets Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Bicalutamide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Bicalutamide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Bicalutamide Tablets Manufacturers, Product Type & Application Table 29. Global Bicalutamide Tablets Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Bicalutamide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Bicalutamide Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Bicalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Bicalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Bicalutamide Tablets Revenue Market Share by Type (2021-2026) Table 36. Global Bicalutamide Tablets Revenue Market Share by Type (2027-2032) Table 37. Global Bicalutamide Tablets Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 39. Global Bicalutamide Tablets Sales by Type (2027-2032) & (k units) Table 40. Global Bicalutamide Tablets Sales Market Share by Type (2021-2026) Table 41. Global Bicalutamide Tablets Sales Market Share by Type (2027-2032) Table 42. Global Bicalutamide Tablets Price by Type (2021-2026) & (US$/unit) Table 43. Global Bicalutamide Tablets Price by Type (2027-2032) & (US$/unit) Table 44. Global Bicalutamide Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Bicalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Bicalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Bicalutamide Tablets Revenue Market Share by Application (2021-2026) Table 48. Global Bicalutamide Tablets Revenue Market Share by Application (2027-2032) Table 49. Global Bicalutamide Tablets Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 51. Global Bicalutamide Tablets Sales by Application (2027-2032) & (k units) Table 52. Global Bicalutamide Tablets Sales Market Share by Application (2021-2026) Table 53. Global Bicalutamide Tablets Sales Market Share by Application (2027-2032) Table 54. Global Bicalutamide Tablets Price by Application (2021-2026) & (US$/unit) Table 55. Global Bicalutamide Tablets Price by Application (2027-2032) & (US$/unit) Table 56. HISUN Company Information Table 57. HISUN Business Overview Table 58. HISUN Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. HISUN Bicalutamide Tablets Product Portfolio Table 60. HISUN Recent Development Table 61. Fosun Pharma Company Information Table 62. Fosun Pharma Business Overview Table 63. Fosun Pharma Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Fosun Pharma Bicalutamide Tablets Product Portfolio Table 65. Fosun Pharma Recent Development Table 66. FORWARD Company Information Table 67. FORWARD Business Overview Table 68. FORWARD Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. FORWARD Bicalutamide Tablets Product Portfolio Table 70. FORWARD Recent Development Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. AstraZeneca Bicalutamide Tablets Product Portfolio Table 75. AstraZeneca Recent Development Table 76. CordenPharma Company Information Table 77. CordenPharma Business Overview Table 78. CordenPharma Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. CordenPharma Bicalutamide Tablets Product Portfolio Table 80. CordenPharma Recent Development Table 81. North America Bicalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Bicalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 84. North America Bicalutamide Tablets Sales by Type (2027-2032) & (k units) Table 85. North America Bicalutamide Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 86. North America Bicalutamide Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 87. North America Bicalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Bicalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 90. North America Bicalutamide Tablets Sales by Application (2027-2032) & (k units) Table 91. North America Bicalutamide Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 92. North America Bicalutamide Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 93. North America Bicalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Bicalutamide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Bicalutamide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Bicalutamide Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 97. North America Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 98. North America Bicalutamide Tablets Sales by Country (2027-2032) & (k units) Table 99. North America Bicalutamide Tablets Sales Price by Country (2021-2026) & (US$/unit) Table 100. North America Bicalutamide Tablets Sales Price by Country (2027-2032) & (US$/unit) Table 101. United States Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 102. Canada Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 103. Mexico Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 104. Europe Bicalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Bicalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 107. Europe Bicalutamide Tablets Sales by Type (2027-2032) & (k units) Table 108. Europe Bicalutamide Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 109. Europe Bicalutamide Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 110. Europe Bicalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Bicalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 113. Europe Bicalutamide Tablets Sales by Application (2027-2032) & (k units) Table 114. Europe Bicalutamide Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 115. Europe Bicalutamide Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 116. Europe Bicalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Bicalutamide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Bicalutamide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Bicalutamide Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 120. Europe Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 121. Europe Bicalutamide Tablets Sales by Country (2027-2032) & (k units) Table 122. Europe Bicalutamide Tablets Sales Price by Country (2021-2026) & (US$/unit) Table 123. Europe Bicalutamide Tablets Sales Price by Country (2027-2032) & (US$/unit) Table 124. Germany Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 125. France Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 126. U.K. Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 127. Italy Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 128. Russia Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 129. Spain Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 132. Sweden Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 133. Poland Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 134. China Bicalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 135. China Bicalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 136. China Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 137. China Bicalutamide Tablets Sales by Type (2027-2032) & (k units) Table 138. China Bicalutamide Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 139. China Bicalutamide Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 140. China Bicalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 141. China Bicalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 142. China Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 143. China Bicalutamide Tablets Sales by Application (2027-2032) & (k units) Table 144. China Bicalutamide Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 145. China Bicalutamide Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 146. Asia Bicalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Bicalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 149. Asia Bicalutamide Tablets Sales by Type (2027-2032) & (k units) Table 150. Asia Bicalutamide Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 151. Asia Bicalutamide Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 152. Asia Bicalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Bicalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 155. Asia Bicalutamide Tablets Sales by Application (2027-2032) & (k units) Table 156. Asia Bicalutamide Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 157. Asia Bicalutamide Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Bicalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Bicalutamide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Bicalutamide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Bicalutamide Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. Asia Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 163. Asia Bicalutamide Tablets Sales by Country (2027-2032) & (k units) Table 164. Asia Bicalutamide Tablets Sales Price by Country (2021-2026) & (US$/unit) Table 165. Asia Bicalutamide Tablets Sales Price by Country (2027-2032) & (US$/unit) Table 166. Japan Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 167. South Korea Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 168. India Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 169. Australia Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Bicalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Bicalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 175. SAMEA Bicalutamide Tablets Sales by Type (2027-2032) & (k units) Table 176. SAMEA Bicalutamide Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 177. SAMEA Bicalutamide Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 178. SAMEA Bicalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Bicalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 181. SAMEA Bicalutamide Tablets Sales by Application (2027-2032) & (k units) Table 182. SAMEA Bicalutamide Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 183. SAMEA Bicalutamide Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 184. SAMEA Bicalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Bicalutamide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Bicalutamide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Bicalutamide Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. SAMEA Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 189. SAMEA Bicalutamide Tablets Sales by Country (2027-2032) & (k units) Table 190. SAMEA Bicalutamide Tablets Sales Price by Country (2021-2026) & (US$/unit) Table 191. SAMEA Bicalutamide Tablets Sales Price by Country (2027-2032) & (US$/unit) Table 192. Brazil Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 193. Argentina Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 194. Chile Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 195. Colombia Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 196. Peru Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 198. Israel Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 199. UAE Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 200. Turkey Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 201. Iran Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 202. Egypt Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Bicalutamide Tablets Distributors List Table 206. Bicalutamide Tablets Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Bicalutamide Tablets Image Figure 2. Global Bicalutamide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bicalutamide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 14 Tablets Per Box Image Figure 5. 28 Tablets Per Box Image Figure 6. Global Bicalutamide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Bicalutamide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Bicalutamide Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Bicalutamide Tablets Revenue (2021-2032) & (US$ Million) Figure 12. Global Bicalutamide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Bicalutamide Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Bicalutamide Tablets Revenue Market Share by Region (2021-2032) Figure 15. Global Bicalutamide Tablets Sales (2021-2032) & (k units) Figure 16. Global Bicalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Bicalutamide Tablets Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Bicalutamide Tablets Sales YoY (2021-2032) & (k units) Figure 19. Europe Bicalutamide Tablets Sales YoY (2021-2032) & (k units) Figure 20. China Bicalutamide Tablets Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Bicalutamide Tablets Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Bicalutamide Tablets Sales YoY (2021-2032) & (k units) Figure 23. Global Bicalutamide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Bicalutamide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Bicalutamide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Bicalutamide Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Bicalutamide Tablets Revenue Market Share by Type (2021-2032) Figure 29. Global Bicalutamide Tablets Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Bicalutamide Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Bicalutamide Tablets Sales Market Share by Type (2021-2032) Figure 32. Global Bicalutamide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Bicalutamide Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Bicalutamide Tablets Revenue Market Share by Application (2021-2032) Figure 35. Global Bicalutamide Tablets Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Bicalutamide Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Bicalutamide Tablets Sales Market Share by Application (2021-2032) Figure 38. North America Bicalutamide Tablets Revenue Share by Type (2021-2032) Figure 39. North America Bicalutamide Tablets Sales Share by Type (2021-2032) Figure 40. North America Bicalutamide Tablets Revenue Share by Application (2021-2032) Figure 41. North America Bicalutamide Tablets Sales Share by Application (2021-2032) Figure 42. North America Bicalutamide Tablets Revenue Share by Country (2021-2032) Figure 43. North America Bicalutamide Tablets Sales Share by Country (2021-2032) Figure 44. Europe Bicalutamide Tablets Revenue Share by Type (2021-2032) Figure 45. Europe Bicalutamide Tablets Sales Share by Type (2021-2032) Figure 46. Europe Bicalutamide Tablets Revenue Share by Application (2021-2032) Figure 47. Europe Bicalutamide Tablets Sales Share by Application (2021-2032) Figure 48. Europe Bicalutamide Tablets Revenue Share by Country (2021-2032) Figure 49. Europe Bicalutamide Tablets Sales Share by Country (2021-2032) Figure 50. China Bicalutamide Tablets Revenue Share by Type (2021-2032) Figure 51. China Bicalutamide Tablets Sales Share by Type (2021-2032) Figure 52. China Bicalutamide Tablets Revenue Share by Application (2021-2032) Figure 53. China Bicalutamide Tablets Sales Share by Application (2021-2032) Figure 54. Asia Bicalutamide Tablets Revenue Share by Type (2021-2032) Figure 55. Asia Bicalutamide Tablets Sales Share by Type (2021-2032) Figure 56. Asia Bicalutamide Tablets Revenue Share by Application (2021-2032) Figure 57. Asia Bicalutamide Tablets Sales Share by Application (2021-2032) Figure 58. Asia Bicalutamide Tablets Revenue Share by Country (2021-2032) Figure 59. Asia Bicalutamide Tablets Sales Share by Country (2021-2032) Figure 60. SAMEA Bicalutamide Tablets Revenue Share by Type (2021-2032) Figure 61. SAMEA Bicalutamide Tablets Sales Share by Type (2021-2032) Figure 62. SAMEA Bicalutamide Tablets Revenue Share by Application (2021-2032) Figure 63. SAMEA Bicalutamide Tablets Sales Share by Application (2021-2032) Figure 64. SAMEA Bicalutamide Tablets Revenue Share by Country (2021-2032) Figure 65. SAMEA Bicalutamide Tablets Sales Share by Country (2021-2032) Figure 66. Bicalutamide Tablets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Bicalutamide Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 14 Tablets Per Box
  • 28 Tablets Per Box
Applications
  • Hospital
  • Clinic
Companies covered
  • HISUN
  • Fosun Pharma
  • FORWARD
  • AstraZeneca
  • CordenPharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bicalutamide Tablets Market by Type
  3. 1.2.1 Global Bicalutamide Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 14 Tablets Per Box
  5. 1.2.3 28 Tablets Per Box
  6. 1.3 Bicalutamide Tablets Market by Application
  7. 1.3.1 Global Bicalutamide Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Bicalutamide Tablets Market Dynamics
  1. 2.1 Bicalutamide Tablets Industry Trends
  2. 2.2 Bicalutamide Tablets Industry Drivers
  3. 2.3 Bicalutamide Tablets Industry Opportunities and Challenges
  4. 2.4 Bicalutamide Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Bicalutamide Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Bicalutamide Tablets Revenue by Region
  3. 3.2.1 Global Bicalutamide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bicalutamide Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Bicalutamide Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Bicalutamide Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Bicalutamide Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Bicalutamide Tablets Sales by Region
  9. 3.4.1 Global Bicalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Bicalutamide Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Bicalutamide Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Bicalutamide Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Bicalutamide Tablets Revenue by Manufacturers
  2. 4.1.1 Global Bicalutamide Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Bicalutamide Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Bicalutamide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bicalutamide Tablets Sales by Manufacturers
  6. 4.2.1 Global Bicalutamide Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Bicalutamide Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Bicalutamide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Bicalutamide Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Bicalutamide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Bicalutamide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Bicalutamide Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Bicalutamide Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Bicalutamide Tablets Market CR5 and HHI
  16. 4.8.2 2025 Bicalutamide Tablets Tier 1, Tier 2, and Tier 3
5 Bicalutamide Tablets Market by Type
  1. 5.1 Global Bicalutamide Tablets Revenue by Type
  2. 5.1.1 Global Bicalutamide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Bicalutamide Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Bicalutamide Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Bicalutamide Tablets Sales by Type
  6. 5.2.1 Global Bicalutamide Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bicalutamide Tablets Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Bicalutamide Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Bicalutamide Tablets Price by Type
6 Bicalutamide Tablets Market by Application
  1. 6.1 Global Bicalutamide Tablets Revenue by Application
  2. 6.1.1 Global Bicalutamide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Bicalutamide Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Bicalutamide Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Bicalutamide Tablets Sales by Application
  6. 6.2.1 Global Bicalutamide Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Bicalutamide Tablets Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Bicalutamide Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Bicalutamide Tablets Price by Application
7 Company Profiles
  1. 7.1 HISUN
  2. 7.1.1 HISUN Company Information
  3. 7.1.2 HISUN Business Overview
  4. 7.1.3 HISUN Bicalutamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 HISUN Bicalutamide Tablets Product Portfolio
  6. 7.1.5 HISUN Recent Developments
  7. 7.2 Fosun Pharma
  8. 7.2.1 Fosun Pharma Company Information
  9. 7.2.2 Fosun Pharma Business Overview
  10. 7.2.3 Fosun Pharma Bicalutamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Fosun Pharma Bicalutamide Tablets Product Portfolio
  12. 7.2.5 Fosun Pharma Recent Developments
  13. 7.3 FORWARD
  14. 7.3.1 FORWARD Company Information
  15. 7.3.2 FORWARD Business Overview
  16. 7.3.3 FORWARD Bicalutamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 FORWARD Bicalutamide Tablets Product Portfolio
  18. 7.3.5 FORWARD Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca Bicalutamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Bicalutamide Tablets Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
  25. 7.5 CordenPharma
  26. 7.5.1 CordenPharma Company Information
  27. 7.5.2 CordenPharma Business Overview
  28. 7.5.3 CordenPharma Bicalutamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CordenPharma Bicalutamide Tablets Product Portfolio
  30. 7.5.5 CordenPharma Recent Developments
8 North America
  1. 8.1 North America Bicalutamide Tablets Market Size by Type
  2. 8.1.1 North America Bicalutamide Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Bicalutamide Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Bicalutamide Tablets Price by Type (2021-2032)
  5. 8.2 North America Bicalutamide Tablets Market Size by Application
  6. 8.2.1 North America Bicalutamide Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Bicalutamide Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Bicalutamide Tablets Price by Application (2021-2032)
  9. 8.3 North America Bicalutamide Tablets Market Size by Country
  10. 8.3.1 North America Bicalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Bicalutamide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Bicalutamide Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Bicalutamide Tablets Market Size by Type
  2. 9.1.1 Europe Bicalutamide Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Bicalutamide Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Bicalutamide Tablets Price by Type (2021-2032)
  5. 9.2 Europe Bicalutamide Tablets Market Size by Application
  6. 9.2.1 Europe Bicalutamide Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Bicalutamide Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Bicalutamide Tablets Price by Application (2021-2032)
  9. 9.3 Europe Bicalutamide Tablets Market Size by Country
  10. 9.3.1 Europe Bicalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Bicalutamide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Bicalutamide Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Bicalutamide Tablets Market Size by Type
  2. 10.1.1 China Bicalutamide Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Bicalutamide Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Bicalutamide Tablets Price by Type (2021-2032)
  5. 10.2 China Bicalutamide Tablets Market Size by Application
  6. 10.2.1 China Bicalutamide Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Bicalutamide Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Bicalutamide Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bicalutamide Tablets Market Size by Type
  2. 11.1.1 Asia Bicalutamide Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Bicalutamide Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Bicalutamide Tablets Price by Type (2021-2032)
  5. 11.2 Asia Bicalutamide Tablets Market Size by Application
  6. 11.2.1 Asia Bicalutamide Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Bicalutamide Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Bicalutamide Tablets Price by Application (2021-2032)
  9. 11.3 Asia Bicalutamide Tablets Market Size by Country
  10. 11.3.1 Asia Bicalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Bicalutamide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Bicalutamide Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bicalutamide Tablets Market Size by Type
  2. 12.1.1 SAMEA Bicalutamide Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Bicalutamide Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Bicalutamide Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Bicalutamide Tablets Market Size by Application
  6. 12.2.1 SAMEA Bicalutamide Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Bicalutamide Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Bicalutamide Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Bicalutamide Tablets Market Size by Country
  10. 12.3.1 SAMEA Bicalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Bicalutamide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Bicalutamide Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Bicalutamide Tablets Value Chain Analysis
  2. 13.1.1 Bicalutamide Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Bicalutamide Tablets Production Mode & Process
  6. 13.2 Bicalutamide Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Bicalutamide Tablets Distributors
  9. 13.2.3 Bicalutamide Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst